-
Committing to cell division may be clue to cancer cell growth
-
Fighting a rare central nervous system tumor with research and optimism
-
Antibody-linked drug shrinks various types of tumors in preclinical study
-
Clinical trial tests combination therapy for prostate cancer
-
Clinical trial tests drug combination in mesothelioma of the lung or abdomen
-
Our Cancer Data Science Lab is seeking experienced tenure track and/or tenure eligible staff to join their team. Fo… https://t.co/U8mgxSIYgZ
-
Prepping for @theNCI Facebook live event - going live in a couple more minutes! https://t.co/KZrrfvXFzS https://t.co/0MXriwvln2
-
Head on over to the @theNCI Facebook page so you won't be late tuning into this exciting live chat!… https://t.co/fqEYHpZ0ab
-
Latest #CCRAdvance from @sowalsky et al online today! #ProstateCancer https://t.co/RHnNbHwmmO
-
Do you have questions about the @NIH pediatric and wildtype GIST clinic or #GIST in general? Ask in the comments se… https://t.co/GaSWz5h9PF
-
Our Pediatric Oncology Branch is conducting an immunotherapy #clinicaltrial for childhood cancer patients with one… https://t.co/JPZCtFWPjn
-
T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remission… https://t.co/DcTXtUG6dT
